Fisher & Paykel Healthcare (FSPKF) Stock Price, News & Analysis

Company Overview

Fisher & Paykel Healthcare Corporation Limited is a New Zealand-based medical device company that develops, manufactures and markets products for respiratory care, acute care and home healthcare. Its technologies are designed to help patients breathe more comfortably and effectively across hospital and home settings.

The company’s product portfolio includes respiratory humidification systems, nasal high-flow therapy products, continuous positive airway pressure (CPAP) and noninvasive ventilation masks, as well as related circuits, interfaces and consumables. These products are used in areas such as intensive care, neonatal care, surgery, obstructive sleep apnea treatment and long-term respiratory support.

Fisher & Paykel Healthcare traces its origins to 1969 and is headquartered in Auckland, New Zealand. The company serves healthcare providers and patients internationally through sales, distribution and operating activities across major markets in North America, Europe, Asia-Pacific and other regions. Lewis Gradon has served as the company’s managing director and chief executive officer.

Key Stats

• Today's Range: $26.99 to $26.99
• 50-Day Range: $25.60 to $28.09
• 52-Week Range: $19.01 to $28.09
• Volume: N/A
• Average Volume: 2,872 shs
• Market Capitalization: N/A
• P/E Ratio: 159.11
• Dividend Yield: 0.24%
• Price Target: N/A
• Consensus Rating: Buy

Fisher & Paykel Healthcare Stock Analysis - MarketRank™

Fisher & Paykel Healthcare scored higher than 8% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: 1.9 / 5
• Analyst Rating: Buy

Consensus Rating

Fisher & Paykel Healthcare has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on no strong buy ratings, 2 buy ratings, no hold ratings, and no sell ratings.

Amount of Analyst Coverage

Fisher & Paykel Healthcare has only been the subject of 2 research reports in the past 90 days.

Earnings and Valuation

• Score: 0.0 / 5
• Proj. Earnings Growth: N/A

Price to Earnings Ratio vs. the Market

The P/E ratio of Fisher & Paykel Healthcare is 159.11, which means that it is trading at a more expensive P/E ratio than the market average P/E ratio of about 26.51.

Price to Earnings Ratio vs. Sector

The P/E ratio of Fisher & Paykel Healthcare is 159.11, which means that it is trading at a more expensive P/E ratio than the Healthcare sector average P/E ratio of about 35.06.

Short Interest

• Score: 0.0 / 5
• Short Interest Level: Bearish

Percentage of Shares Shorted

Short Interest Ratio / Days to Cover

Fisher & Paykel Healthcare has a short interest ratio ("days to cover") of 297, which indicates bearish sentiment.

Change versus previous month

Short interest in Fisher & Paykel Healthcare has recently increased by 1,629.02%, indicating that investor sentiment is decreasing significantly.

Dividend

• Score: 1.7 / 5
• Dividend Strength: Weak

Dividend Yield

Fisher & Paykel Healthcare pays a meaningful dividend of 2.29%, higher than the bottom 25% of all stocks that pay dividends.

Dividend Growth

Fisher & Paykel Healthcare does not have a long track record of dividend growth.

Dividend Coverage

The dividend payout ratio of Fisher & Paykel Healthcare is 38.45%. This payout ratio is at a healthy, sustainable level, below 75%.

News and Social Media

• Score: 0.6 / 5
• News Sentiment: N/A

News Sentiment

Fisher & Paykel Healthcare has a news sentiment score of -1.00. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.58 average news sentiment score of Healthcare companies.

News Coverage This Week

MarketBeat has tracked 1 news article for Fisher & Paykel Healthcare this week, compared to 0 articles on an average week.

Company Ownership

• Score: 0.4 / 5
• Insider Trading: N/A

Insider Buying vs. Insider Selling

In the past three months, Fisher & Paykel Healthcare insiders have not sold or bought any company stock.

Percentage Held by Institutions

31.42% of the stock of Fisher & Paykel Healthcare is held by institutions.

Company Calendar

• Today: 11/12/2026
• Next Earnings (Estimated): 11/26/2026

Industry, Sector and Symbol

• Stock Exchange: OTCMKTS
• Sector: Healthcare
• Industry: Healthcare Equipment & Supplies
• Sub-Industry: Healthcare Equipment
• Current Symbol: OTCMKTS:FSPKF
• CIK: N/A
• Web: www.fphcare.com
• Phone: (649) 574-0100
• Fax: N/A
• Employees: 7,661
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): N/A
• Trailing P/E Ratio: 159.11
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: N/A
• Free Float: N/A
• Market Cap: N/A
• Optionable: Not Optionable
• Beta: N/A